GSTM1 and breast carcinoma: Moreover, Yang et al., (2005) indicated that there was no relation to any of the GSTM1 or GSTT1 polymorphisms as potential role in prognosis to the clinical outcomes and overall survival of breast cancer patients after chemotherapy.